Head to head
Arhaus vs Ulta Beauty
Side-by-side on the measures that matter, with a plain-English read. Full detail: ARHS · ULTA
ARHS
Arhaus
13.00+0.54%
1-year price shape — +53% over the period
Quant Rating C · 87/100
vs
ULTA
Ulta Beauty
615.74-2.16%
1-year price shape — +24% over the period
Quant Rating C · 67/100
1-year performance, rebased to 100
Ulta Beauty edges it on the scoreable measures. Ulta Beauty trades cheapest on trailing earnings; Ulta Beauty earns the most per share.
| ARHS | ULTA | |
|---|---|---|
| Snapshot | ||
| Sector | Specialty Retail | Specialty Retail |
| Last price | 13.00 | 615.74 |
| Change today | +0.54% | -2.16% |
| 1-year return | +52.8% | +24.0% |
| Market cap | $1.84B | $26.33B |
| 52-week range | 5.57 – 15.17 | 443.60 – 714.97 |
| Valuation | ||
| P/E (TTM) | 28.26 | 22.42 |
| P/E percentile, own 5-yr range | 91st | 91st |
| P/B | 4.33 | 9.96 |
| Dividend yield | 0.00% | 0.00% |
| Profitability & growth | ||
| EPS (TTM) | 0.48 | 25.64 |
| Net profit (TTM) | $68.04M | $1.10B |
| Revenue (TTM) | $1.43B | $12.96B |
| Provider revenue period date | 2026-09-29 | 2026-07-31 |
| Revenue growth (YoY) | +6.8% | +8.9% |
| Gross margin | 39.8% | 39.3% |
| Operating margin | 6.1% | 12.6% |
| Net margin | 4.5% | 9.3% |
| Free cash flow (TTM) | $104.76M | $1.15B |
| Provider cash-flow period date | 2026-09-29 | 2026-07-31 |
| Ownership & sentiment | ||
| Institutional ownership | 70.4% | 101.5% |
| Insider activity (12mo) | 38 buy / 12 sell | 35 buy / 11 sell |
| Short interest (% of float) | 5.3% | 4.8% |
| Analyst consensus | 67% buy / 33% hold (9) | 76% buy / 18% hold / 6% sell (17) |
| Analyst price target | $14 (+8%) | $651 (+6%) |
| StockVane view | ||
| StockVane Quant Rating | C (87) | C (67) |
| Company | ||
| Employees | 2,800 | 65,000 |
| Founded | 1986 | 1990 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.